Antiapoptotic effects of roscovitine on camptothecin-induced DNA damage in neuroblastoma cells

Apoptosis

Volumn 16, Issue 5, 2011, Pages 536-550

  Pizarro, Javier G ^a   Folch, Jaume ^b   Junyent, Felix ^a,b   Verdaguer, Ester ^a   Auladell, Carme ^a   Beas Zarate, Carlos ^c   Pallàs, Mercè ^a   Camins, Antoni ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b FACULTAT DE MEDICINA I CIÈNCIES DE LA SALUT   (Spain)

^c INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

Ataxia telangiectasia mutated; Camptothecin; Cell cycle; Roscovitine

Indexed keywords

2 MORPHOLINO 6 (1 THIANTHRENYL) 4 PYRANONE; ATM PROTEIN; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CAFFEINE; CALPAIN; CALPEPTIN; CAMPTOTHECIN; CASPASE 3; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE 5; ROSCOVITINE;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL DEATH; CONTROLLED STUDY; DNA DAMAGE; DRUG EFFECT; ENZYME ACTIVATION; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ATAXIA TELANGIECTASIA;

EID: 79955844072     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-011-0583-3     Document Type: Article

References (38)

1. K Goteti CE Garner L Utley, et al. 2010 Preclinical pharmacokinetic/ pharmacodynamic models to predict synergistic effects of co-administered anti-cancer agents Cancer Chemother Pharmacol 66 245 254 19841922 10.1007/s00280-009-1153-z 1:CAS:528:DC%2BC3cXmt1alsLc%3D
2. V Krystof S Uldrijan 2010 Cyclin-dependent kinase inhibitors as anticancer drugs Curr Drug Targets 11 291 302 20210754 10.2174/ 138945010790711950 1:CAS:528:DC%2BC3cXkt1emsr0%3D
3. M Abal R Bras-Goncalves JG Judde 2004 Enhanced sensitivity to irinotecan by Cdk1 inhibition in the p53-deficient HT29 human colon cancer cell line Oncogene 23 1737 1744 15001986 10.1038/sj.onc.1207299 1:CAS:528: DC%2BD2cXhslGisb4%3D (Pubitemid 38445165)
4. V Zuco V Benedetti F Zunino 2010 ATM- and ATR-mediated response to DNA damage induced by a novel camptothecin, ST1968 Cancer Lett 292 186 196 20042274 10.1016/j.canlet.2009.12.001 1:CAS:528:DC%2BC3cXkvFemtrs%3D
5. IT Aldoss T Tashi AK Ganti 2009 Seliciclib in malignancies Expert Opin Investig Drugs 18 1957 1965 19938906 10.1517/13543780903418445 1:CAS:528:DC%2BD1MXhsVOhtrbO
6. JD Zolnierczyk JZ Błoński T Robak ZM Kiliańska J Wesierska-Gadek 2009 Roscovitine triggers apoptosis in B-cell chronic lymphocytic leukemia cells with similar efficiency as combinations of conventional purine analogs with cyclophosphamide Ann NY Acad Sci 1171 124 131 19723046 10.1111/j.1749-6632.2009.04903.x 1:CAS:528:DC%2BD1MXht1SntbrP
7. S Bach M Knockaert J Reinhardt, et al. 2005 Roscovitine targets, protein kinases and pyridoxal kinase J Biol Chem 280 31208 31219 15975926 10.1074/jbc.M500806200 1:CAS:528:DC%2BD2MXpsVCmurY%3D (Pubitemid 41291858)
8. MS Abaza AM Bahman RJ Al-Attiyah 2008 Roscovitine synergizes with conventional chemo-therapeutic drugs to induce efficient apoptosis of human colorectal cancer cells World J Gastroenterol 14 5162 5175 18777593 10.3748/wjg.14.5162 1:CAS:528:DC%2BD1MXmtVClsA%3D%3D
9. MV Appleyard MA O'Neill KE Murray, et al. 2009 Seliciclib (CYC202, R-roscovitine) enhances the antitumor effect of doxorubicin in vivo in a breast cancer xenograft model Int J Cancer 124 465 472 19003963 10.1002/ijc.23938 1:CAS:528:DC%2BD1MXhvFeitA%3D%3D
10. LA Lambert N Qiao KK Hunt, et al. 2007 Autophagy: a novel mechanism of synergistic cytotoxicity between doxorubicin and roscovitine in a sarcoma model Cancer Res 68 7966 7974 10.1158/0008-5472.CAN-08-1333
11. MR Sadaie R Mayner J Doniger 2004 A novel approach to develop anti-HIV drugs: adapting non-nucleoside anticancer chemotherapeutics Antiviral Res 61 1 18 14670589 10.1016/j.antiviral.2003.09.004 1:CAS:528:DC%2BD3sXps1Grt7Y%3D (Pubitemid 37508525)
12. NR DeStefino AA Pilato M Dittrich, et al. 2010 (R)-roscovitine prolongs the mean open time of unitary N-type calcium channel currents Neuroscience 167 838 849 20188151 10.1016/j.neuroscience.2010.02.041 1:CAS:528: DC%2BC3cXks1Wmu7s%3D
13. W Lu L Chen Y Peng J Chen 2001 Activation of p53 by roscovitine-mediated suppression of MDM2 expression Oncogene 20 3206 3216 11423970 10.1038/sj.onc.1204412 1:CAS:528:DC%2BD3MXks1GktL0%3D (Pubitemid 32553673)
14. SL Maude GH Enders 2005 Cdk Inhibition in human cells compromises Chk1 function and activates a DNA damage response Cancer Res 65 780 786 15705874 1:CAS:528:DC%2BD2MXhtVWntrc%3D (Pubitemid 40216435)
15. B Tian Q Yang Z Mao 2009 Phosphorylation of ATM by Cdk5 mediates DNA damage signalling and regulates neuronal death Nat Cell Biol 11 211 218 19151707 10.1038/ncb1829 1:CAS:528:DC%2BD1MXht1Oqtrc%3D
16. JG Pizarro M Yeste-Velasco JL Esparza, et al. 2008 The antiproliferative activity of melatonin in B65 rat dopaminergic neuroblastoma cells is related to the downregulation of cell cycle-related genes J Pineal Res 45 8 16 18284548 10.1111/j.1600-079X.2007.00548.x 1:CAS:528:DC%2BD1cXpvVOnsLw%3D (Pubitemid 351986256)
17. E Crescenzi G Palumbo HJ Brady 2005 Roscovitine modulates DNA repair and senescence: implications for combination chemotherapy Clin Cancer Res 11 8158 8171 16299248 10.1158/1078-0432.CCR-05-1042 1:CAS:528:DC%2BD2MXht1entrzK (Pubitemid 41698760)
18. AB Hui S Yue W Shi NM Alajez, et al. 2009 Therapeutic efficacy of seliciclib in combination with ionizing radiation for human nasopharyngeal carcinoma Clin Cancer Res 15 3716 3724 19470731 10.1158/1078-0432.CCR-08-2790 1:CAS:528:DC%2BD1MXmsFOjtbk%3D
19. JG Pizarro J Folch JL Esparza, et al. 2009 A molecular study of pathways involved in the inhibition of cell proliferation in neuroblastoma B65 cells by the GSK-3 inhibitors lithium and SB-415286 J Cell Mol Med 13 3906 3917 18624766 10.1111/j.1582-4934.2008.00389.x
20. M Yeste-Velasco J Folch M Pallàs A Camins 2009 The p38 (MAPK) signalling pathway regulates neuronal apoptosis through the phosphorylation of the retinoblastoma protein Neurochem Int 54 99 105 19007833 10.1016/j.neuint. 2008.10.004 1:CAS:528:DC%2BD1MXit1KrtLs%3D
21. JG Pizarro J Folch A Vazquez De la Torre, et al. 2009 Oxidative stress-induced DNA damage and cell cycle regulation in B65 dopaminergic cell line Free Radic Res 43 985 994 19657808 10.1080/10715760903159188 1:CAS:528:DC%2BD1MXhtFWhurnP
22. Ye Y, Tinari A, Malorni W, Lockshin RA, Zakeri Z. Activation of cyclin-dependent kinase 5 is a consequence of cell death. J Biomed Biotechnol 2009:805709
23. JH Lee KT Kim 2007 Regulation of cyclin-dependent kinase 5 and p53 by ERK1/2 pathway in the DNA damage-induced neuronal death J Cell Physiol 210 784 797 17117479 10.1002/jcp.20899 1:CAS:528:DC%2BD2sXht1eju7s%3D (Pubitemid 46185048)
24. Lee JH, Jeong MW, Kim W, Choi YH, Kim KT (2008) Cooperative roles of c-Abl and Cdk5 in regulation of p53 in response to oxidative stress. J Biol Chem 283:19826-35
25. A Borgne I Versteege M Mahé, et al. 2006 Analysis of cyclin B1 and CDK activity during apoptosis induced by camptothecin treatment Oncogene 25 7361 7372 16785996 10.1038/sj.onc.1209718 1:CAS:528:DC%2BD28Xht1Kisr7O (Pubitemid 44853427)
26. M Hamdane A Bretteville AV Sambo, et al. 2005 p25/Cdk5-mediated retinoblastoma phosphorylation is an early event in neuronal cell death J Cell Sci 118 1291 1304 15741232 10.1242/jcs.01724 1:CAS:528:DC%2BD2MXjs1Chsb0%3D (Pubitemid 40528698)
27. M Hamdane L Buée 2007 The complex p25/Cdk5 kinase in neurofibrillary degeneration and neuronal death: the missing link to cell cycle Biotechnol J 2 967 977 17571276 10.1002/biot.200700059 1:CAS:528: DC%2BD2sXpsFemsL0%3D (Pubitemid 47377104)
28. JG Pizarro J Folch AV de la Torre, et al. 2010 ATM is involved in cell-cycle control through the regulation of retinoblastoma protein phosphorylation J Cell Biochem 110 210 218 20213763 1:CAS:528: DC%2BC3cXltVGit70%3D
29. D Kim CL Frank MM Dobbin RK Tsunemoto, et al. 2008 Stabilization and activation of p53 induced by Cdk5 contributes to neuronal cell death J Cell Sci 120 2259 2271
30. A Camins N Crespo-Biel F Junyent, et al. 2009 Calpains as a target for therapy of neurodegenerative diseases: putative role of lithium Curr Drug Metab 10 433 447 19689241 10.2174/138920009788898028 1:CAS:528:DC%2BD1MXhtVGhtb%2FE
31. A Camins E Verdaguer J Folch, et al. 2006 The role of CDK5/P25 formation/inhibition in neurodegeneration Drug News Perspect 19 453 460 17160145 10.1358/dnp.2006.19.8.1043961 1:CAS:528:DC%2BD2sXls1Cktw%3D%3D (Pubitemid 46050819)
32. Chang K-H, de Pablo Y, Lee HP, et al. (2010) Cdk5 is a Major Regulator of p38 Cascade: Relevance to Neurotoxicity in Alzheimer's Disease. J. Alzheimer's Dis. doi: 10.1111/j.1471-4159.2010.06687.x
33. B Ikiz S Przedborski 2008 A sequel to the tale of p25/Cdk5 in neurodegeneration Neuron. 60 731 732 19081365 10.1016/j.neuron.2008.11.020 1:CAS:528:DC%2BD1cXhsFahs73L
34. KH Sun HG Lee MA Smith K Shah 2009 Direct and indirect roles of cyclin-dependent kinase 5 as an upstream regulator in the c-Jun NH2-terminal kinase cascade: relevance to neurotoxic insults in Alzheimer's disease Mol Biol Cell 20 4611 4619 19776350 10.1091/mbc.E09-05-0433 1:CAS:528:DC%2BD1MXhsVSksLrJ
35. D Kim CL Frank MM Dobbin, et al. 2008 Deregulation of HDAC1 by p25/Cdk5 in neurotoxicity Neuron 60 803 817 19081376 10.1016/j.neuron.2008.10.015 1:CAS:528:DC%2BD1cXhsFahs7rE
36. A Renton S Llanos X Lu 2003 Hypoxia induces p53 through a pathway distinct from most DNA-damaging and stress-inducing agents Carcinogenesis 24 1177 1182 12807744 10.1093/carcin/bgg044 1:CAS:528:DC%2BD3sXlvF2rtLo%3D (Pubitemid 36927057)
37. E Huang D Qu Y Zhang K Venderova, et al. 2010 The role of Cdk5-mediated apurinic/apyrimidinic endonuclease 1 phosphorylation in neuronal death Nat Cell Biol 12 563 571 20473298 10.1038/ncb2058 1:CAS:528:DC%2BC3cXmslShtbk%3D
38. M Federico CE Symonds L Bagella, et al. 2010 Roscovitine (Seliciclib) prevents DNA damage-induced cyclin A1 upregulation and hinders non-homologous end-joining (NHEJ) DNA repair Mol Cancer 9 208 20684776 10.1186/1476-4598-9-208